Overdiagnosis and overuse of diagnostic and screening tests in low-income and middle-income countries: a scoping review
File version
Version of Record (VoR)
Author(s)
Arab-Zozani, Morteza
Abukmail, Eman
Greenwood, Hannah
Pathirana, Thanya
Clark, Justin
Kopitowski, Karin
Johansson, Minna
Born, Karen
Lang, Eddy
Moynihan, Ray
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
Objective Overdiagnosis and overuse of healthcare services harm individuals, take resources that could be used to address underuse, and threaten the sustainability of health systems. These problems are attracting increasing attention in low-income and middle-income countries (LMICs). Unaware of any review of relevant evidence, we conducted a scoping review of the evidence around overdiagnosis and overuse of diagnostic and screening tests in LMICs. Design Scoping review. Methods We searched PubMed, Embase, PsycINFO, Global Index Medicus for relevant studies published until 24 May 2021, with no restrictions on date or language. We categorised included studies by major focus (overdiagnosis, overuse of tests, or both) and main themes (presence or estimates of extent; drivers; consequences and solutions). Results We identified 2763 unique records and included 162 articles reporting on 154 studies across 55 countries, involving over 2.8 million participants and/or requests for tests. Almost half the studies focused on overdiagnosis (70; 45.5%), one-third on overuse of tests (61; 39.6%) and one-fifth on both (23; 14.9%). Common overdiagnosed conditions included malaria (61; 39.6%) and thyroid cancer (25; 16.2%), estimated to be >70% in China. Overused tests included imaging (n=25 studies) such as CT and MRI; laboratory investigations (n=18) such as serological tests and tumour markers; and procedures (n=14) such as colonoscopy. Drivers included fear of conflict with patients and expanding disease definitions. Common consequences included unnecessary treatments such as antimalarials, and wasted resources, with costs of malaria overdiagnosis estimated at US$86 million in Sudan in 1 year alone. Only 9% of studies discussed solutions, which included addressing inappropriately lowered diagnostic thresholds and reforming test-ordering processes. Conclusions Overdiagnosis and overuse of tests are widespread in LMICs and generate significant harm and waste. Better understanding of the problems and robust evaluation of solutions is needed, informed by a new global alliance of researchers and policy-makers.
Journal Title
BMJ Global Health
Conference Title
Book Title
Edition
Volume
7
Issue
10
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Item Access Status
Note
Access the data
Related item(s)
Subject
Public health
Health policy
Science & Technology
Life Sciences & Biomedicine
Public, Environmental & Occupational Health
Systematic review
Health systems
Persistent link to this record
Citation
Albarqouni, L; Arab-Zozani, M; Abukmail, E; Greenwood, H; Pathirana, T; Clark, J; Kopitowski, K; Johansson, M; Born, K; Lang, E; Moynihan, R, Overdiagnosis and overuse of diagnostic and screening tests in low-income and middle-income countries: a scoping review, BMJ Global Health, 2022, 7 (10), pp. e008696